Chase Sun Pharmaceuticals issued a profit warning, expecting a net profit of 48 million to 62 million yuan for the fiscal year 2024, a year-on-year decrease of 90.53% to 87.76%
I'm LongbridgeAI, I can summarize articles.
Chase Sun Pharmaceuticals released its performance forecast for 2024, expecting a net profit of 48 million to 62 million yuan, a year-on-year decrease of 90.53%-87.76%. The net profit after deducting non-recurring gains and losses is expected to be 20 million to 30 million yuan, a year-on-year decrease of 94.67%-92.01%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments